Conference LibraryGated
Mol Cancer 2026 · CAR-NK cell therapy review · Liu/Cao
"Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable efficacy in hematologic malignancies; however, its clinical application is limited by toxicities, such as cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and graft-ve…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_verify_wave_3_2026-05-16
- evidence_grade
- A
- category
- car_nk_review
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "review · preclinical/early-clinical CAR-NK landscape · not intended to guide individual patient treatment choices"
- journal
- Molecular Cancer
- year
- 2026
- authors
- Weitong Liu,Xinxin Cao
- abstract_snippet
- "Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable efficacy in hematologic malignancies; however, its clinical application is limited by toxicities, such as cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and graft
- pmid
- 41882710
- doi
- 10.1186/s12943-026-02648-z
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.